Asia Pacific Multi Cancer Early Detection Market Size & Outlook

The multi cancer early detection market in Asia Pacific is expected to reach a projected revenue of US$ 404.8 million by 2030. A compound annual growth rate of 11.2% is expected of Asia Pacific multi cancer early detection market from 2023 to 2030.
Revenue, 2022 (US$M)
$172.7
Forecast, 2030 (US$M)
$404.8
CAGR, 2023 - 2030
11.2%
Report Coverage
Asia Pacific

Asia Pacific multi cancer early detection market, 2018-2030 (US$M)

Asia

Asia Pacific multi cancer early detection market highlights

  • The Asia Pacific multi cancer early detection market generated a revenue of USD 172.7 million in 2022.
  • The market is expected to grow at a CAGR of 11.2% from 2023 to 2030.
  • In terms of segment, gene panel, ldt & others was the largest revenue generating type in 2022.
  • Gene Panel, LDT & Others is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2023 to 2030.


Asia Pacific data book summary

Market revenue in 2022USD 172.7 million
Market revenue in 2030USD 404.8 million
Growth rate11.2% (CAGR from 2022 to 2030)
Largest segmentGene panel, ldt & others
Fastest growing segmentGene Panel, LDT & Others
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGene Panel, LDT & Others
Key market players worldwideIllumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.2% of the global multi cancer early detection market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • North America is the fastest growing regional market and is projected to reach USD 1,289.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Multi Cancer Early Detection Market Companies

Name Profile # Employees HQ Website

Asia Pacific multi cancer early detection market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.


Gene panel, ldt & others was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the Asia Pacific multi cancer early detection market based on gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific MCED market is expected to grow at a lucrative rate owing to various factors, such as increasing healthcare reforms. Other factors contributing to market growth are improving healthcare infrastructure, a growing population, and rising number of local companies entering the market. Asia Pacific has a large population and high prevalence of cancer.

Thus, usage of screening tests for cancer has increased in the past few years owing to growing government initiatives, such as free screening for cervical cancer, breast cancer, & lung cancer, as well as increasing collaborations between governments, research institutes, & companies for distribution & supply of these tests.

In Asia Pacific, cancer has drawn more attention as a result of demographic shifts brought on by urbanization, aging populations, and economic expansion. High prevalence of health risk factors, such as increasing alcohol & cigarette consumption, poor diets, and sedentary lifestyle, are contributing to the increasing prevalence of cancers.

Reasons to subscribe to Asia Pacific multi cancer early detection market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific multi cancer early detection market databook

  • Our clientele includes a mix of multi cancer early detection market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific multi cancer early detection market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific multi cancer early detection market size, by country, 2018-2030 (US$M)

Asia Pacific Multi Cancer Early Detection Market Outlook Share, 2022 & 2030 (US$M)

Asia Pacific multi cancer early detection market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more